150 related articles for article (PubMed ID: 38421920)
1. Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth.
Wisner KL; Avram MJ; George AL; Abramova TV; Yang A; Caritis SN; Costantine MM; Stika CS
J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):100-106. PubMed ID: 38421920
[TBL] [Abstract][Full Text] [Related]
2. Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.
Scordo MG; Spina E; Dahl ML; Gatti G; Perucca E
Basic Clin Pharmacol Toxicol; 2005 Nov; 97(5):296-301. PubMed ID: 16236141
[TBL] [Abstract][Full Text] [Related]
3. Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.
LLerena A; Dorado P; Berecz R; González AP; Peñas-LLedó EM
Eur J Clin Pharmacol; 2004 Feb; 59(12):869-73. PubMed ID: 14726986
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
Wang Z; Wang S; Huang M; Hu H; Yu L; Zeng S
Chirality; 2014 Mar; 26(3):166-73. PubMed ID: 24464553
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Transplacental Transfer of Fluoxetine Enantiomers and Their Metabolites in Pregnant Women.
Carvalho DM; Lanchote VL; Filgueira GCO; Nardotto GHB; Duarte G; Cavalli RC; Moisés ECD
Clin Pharmacol Ther; 2019 Apr; 105(4):1003-1008. PubMed ID: 30346625
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers.
Eap CB; Bondolfi G; Zullino D; Savary-Cosendai L; Powell-Golay K; Kosel M; Baumann P
J Clin Psychopharmacol; 2001 Jun; 21(3):330-4. PubMed ID: 11386497
[TBL] [Abstract][Full Text] [Related]
7. Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.
Sit D; Perel JM; Luther JF; Wisniewski SR; Helsel JC; Wisner KL
J Clin Psychopharmacol; 2010 Aug; 30(4):381-6. PubMed ID: 20631556
[TBL] [Abstract][Full Text] [Related]
8. Identification of the human cytochromes p450 responsible for in vitro formation of R- and S-norfluoxetine.
Ring BJ; Eckstein JA; Gillespie JS; Binkley SN; VandenBranden M; Wrighton SA
J Pharmacol Exp Ther; 2001 Jun; 297(3):1044-50. PubMed ID: 11356927
[TBL] [Abstract][Full Text] [Related]
9. Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients.
Gassó P; Rodríguez N; Mas S; Pagerols M; Blázquez A; Plana MT; Torra M; Lázaro L; Lafuente A
Pharmacogenomics J; 2014 Oct; 14(5):457-62. PubMed ID: 24663076
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of fluoxetine and norfluoxetine enantiomers using isotope discrimination mass spectroscopy solution method and its application in the CYP2C9-mediated stereoselective interactions.
Yu L; Wang S; Jiang H; Zhou H; Zeng S
J Chromatogr A; 2012 May; 1236():97-104. PubMed ID: 22436668
[TBL] [Abstract][Full Text] [Related]
11. Fast evaluation of enantioselective drug metabolism by electrophoretically mediated microanalysis: application to fluoxetine metabolism by CYP2D6.
Asensi-Bernardi L; Martín-Biosca Y; Escuder-Gilabert L; Sagrado S; Medina-Hernández MJ
Electrophoresis; 2013 Dec; 34(22-23):3214-20. PubMed ID: 24105868
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy.
Ververs FF; Voorbij HA; Zwarts P; Belitser SV; Egberts TC; Visser GH; Schobben AF
Clin Pharmacokinet; 2009; 48(10):677-83. PubMed ID: 19743889
[TBL] [Abstract][Full Text] [Related]
13. Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.
Lind AB; Reis M; Bengtsson F; Jonzier-Perey M; Powell Golay K; Ahlner J; Baumann P; Dahl ML
Clin Pharmacokinet; 2009; 48(1):63-70. PubMed ID: 19071885
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
Jannuzzi G; Gatti G; Magni P; Spina E; Pacifici R; Zuccaro P; Torta R; Guarneri L; Perucca E
Ther Drug Monit; 2002 Oct; 24(5):616-27. PubMed ID: 12352933
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450.
Stevens JC; Wrighton SA
J Pharmacol Exp Ther; 1993 Aug; 266(2):964-71. PubMed ID: 8355218
[TBL] [Abstract][Full Text] [Related]
16. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding.
Kim J; Riggs KW; Misri S; Kent N; Oberlander TF; Grunau RE; Fitzgerald C; Rurak DW
Br J Clin Pharmacol; 2006 Feb; 61(2):155-63. PubMed ID: 16433870
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.
Ereshefsky L; Riesenman C; Lam YW
Clin Pharmacokinet; 1995; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia.
Stedman CA; Begg EJ; Kennedy MA; Roberts R; Wilkinson TJ
Hum Psychopharmacol; 2002 Jun; 17(4):187-90. PubMed ID: 12404686
[TBL] [Abstract][Full Text] [Related]
20. Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.
LLerena A; Dorado P; Berecz R; González A; Jesús Norberto M; de la Rubia A; Cáceres M
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):25-31. PubMed ID: 12450521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
